GAA p.Ser626Pro
c.1876T>C · rs1235035841 · VCV1483143
Computational evidence
| Protein change | ||
| AlphaMissense | 0.5165 | ambiguous |
|---|---|---|
| REVEL | 0.402 | indeterminate |
| SaProt | LLR -9.27 | tolerated |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 1.1 | GERP -1.8, phastCons 0.005 |
| Regional constraint | o/e 1.03 | unconstrained · MANE · 15 kb · p 0.22 · regional, not allelic |
| Overall | ||
| CADD | 17.73 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- GAA
- Protein
- p.Ser626Pro
- Coding
- c.1876T>C
- MANE Select
- NM_000152
- dbSNP
- rs1235035841
- Type
- single nucleotide variant
- Location
- chr17:80112699 (GRCh38)
- Gene constraint
- LOEUF 1.008 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 92.32 · 19 PDB
- Residue 626
- an α-helix
Disease context
glycogen storage disease II — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Glycogen storage disease due to acid maltase deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Antenatal, Childhood, Infancy, Neonatal
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- GAA p.Ser626Ala Conflicting classifications of pathogenicity ★ ⚠ same residue
- GAA p.Ser626= Likely benign ★ same residue
- GAA c.1076-1G>C Pathogenic ★★★ same condition
- GAA c.1076-22T>G Pathogenic ★★★ same condition
- GAA c.1194+5G>A Likely pathogenic ★★★ same condition
- GAA c.1326+1G>A Pathogenic ★★★ same condition
- GAA c.1327-2A>G Pathogenic ★★★ same condition
- GAA c.1437+1G>A Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gaa-p-ser626pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown